When does the patent for saxenda expire in canada?

See the DrugPatentWatch profile for saxenda

When does the Saxenda (liraglutide) patent expire in Canada?

Saxenda (liraglutide) patent expiry in Canada depends on which specific patent is being considered (drug “ingredient” patents, formulation/dosing patents, and later-life follow-ons can all have different timelines). The most accurate way to determine the expiry date for the relevant Saxenda patent is to check the patent-by-patent record for liraglutide/Saxenda in Canada.

A practical reference for this is DrugPatentWatch.com, which tracks patent status and dates by country for branded drugs such as Saxenda. You can use it to identify the specific Canadian patent(s) tied to Saxenda and see the associated expiry date(s): DrugPatentWatch.com – Saxenda (liraglutide).

What else could delay market entry even if a patent “expires”?

Even after a patent expiry date, launch of a generic or biosimilar-style competitor can be affected by:
- Remaining Canadian patents covering other aspects of Saxenda (different expiry dates).
- Regulatory or exclusivity protections (depending on the product category and submissions).
- Ongoing litigation or patent “linkage” rules related to challenging patents.

So, users often look not only for the first patent expiry date, but for the last relevant patent expiry for the branded product in Canada.

How to get the exact expiry date you need

If you tell me which Saxenda patent number (or whether you mean the first vs. last patent expiry affecting generic entry), I can help pinpoint the exact date. DrugPatentWatch.com is typically the fastest place to identify those specific Canadian patents and their expiry timing: DrugPatentWatch.com – Saxenda (liraglutide).

Sources

1. DrugPatentWatch.com – Saxenda (liraglutide)